During the past decade, MSD (Pty) LTD South Africa conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MSD (Pty) LTD South Africa" are "Advanced Cancer" (1 trials), "Advanced Solid Tumors" (1 trials), "Anal Cancer" (1 trials), "Anal Carcinoma" (1 trials) and "Asthma" (1 trials). Many other conditions were trialed in "MSD (Pty) LTD South Africa" in a lesser frequency.

Most popular intervention types in "MSD (Pty) LTD South Africa" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "ENG-E2 125 μg/300 μg vaginal ring" (1 trials), "LNG-EE 150 μg/30 μg COC" (1 trials), "MK-1029" (1 trials), "Placebo for MK-1029" (1 trials) and "pembrolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "MSD (Pty) LTD South Africa" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "MSD (Pty) LTD South Africa". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in MSD (Pty) LTD South Africa, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in MSD (Pty) LTD South Africa, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".